Awards

The following abstracts received awards:

Best Abstracts Awards (11)

CAN SOLUBLE ADHESION MOLECULES BE USED AS A DIAGNOSTIC MARKER IN CHILDREN WITH BRONCHIOLITIS ?

Mehmet Emre Tascilar¹, Vedat Köseoğlu¹, Vural Kesik¹, Yasemin Kurt², Mustafa Gülgün¹, Erkan Demirkaya¹, Erol Kısmet¹

1 Gülhane Military Medical Faculty, Department of Pediatrics, Etlik, Ankara, Turkey, 2 Gülhane Military Medical Faculty, Department of Biochemistry, Etlik, Ankara, Turkey

DOES A CORRELATION EXIST BETWEEN OBSTRUCTIVE APNOEA - HYPOPNOEA SYNDROME DURING SLEEP (OSAHS) AND ADENOTONSILAR HYPERTROPHY, BODY MASS INDEX (BMI) AND NECK DIMENSIONS IN CHILDHOOD?

Afroditi Sakellaropoulou¹, John Gountakos², Maria Avgeri¹, Konstantinos Markou¹, Maria Hatzistilianou¹, Maria Eboriadou¹, Victor Aivazis¹, Fani Athanasiadou-Piperopoulou¹

1.  2nd Department of Pediatrics, AXEPA University General Hospital, Thessaloniki, Greece, 2  Department of Otolaryngology, AHEPA University Hospital, Thessaloniki, Greece, 3 1st Department of Pediatrics, Hippokratio General Hospital of Thessaloniki, Thessaloniki, Greece

CAROTID INTIMA-MEDIA THICKNESS IN OVERWEIGHT AND OBESE CHILDREN: CARDIOVASCULAR RISK FACTORS EVALUATION
 
Ana Leite¹, Ana Santos², Lúcia Gomes¹, Elizabeth Marques¹, Miguel Veloso³, Miguel Costa¹

1. Department of Paediatrics, Centro Hospitalar Entre Douro e Vouga, Santa Maria da Feira, Portugal, 2 Department of Hygiene and Epidemiology, University of Porto Medical School, Oporto, Portugal, 3 Department of Neurology, Centro Hospitalar de Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal

INTEGRATED REAL-TIME CONTINUOUS GLUCOSE MONITORING/INSULIN PUMP SYSTEM (PRT) USEFULNESS IN 122 CHILDREN WITH TYPE 1 DIABETES. A 3-YEAR FOLLOW-UP STUDY

Andrea E. Scaramuzza¹, Riccardo Bonfanti², Pietro Buono³, Dario Iafusco⁴, Fortunato. Lombardo⁵, Ivana  Rabbone⁶, Riccardo Schiaffini⁷, Nicoletta Sulli⁸, Sonia Toni⁹, Elisa Giani¹, Valentina Pivetti¹, Gian Vincenzo Zuccotti¹, Diabetes Study Group of Italian Society od Paediatric Endocrinology and Diabetology (ISPED)

1 University of Milano - Luigi Sacco Hospital, Paediatrics, Milano, Italy, 2 San Raffaele Institute, Paediatrics, Milano, Italy, 3 Federico II University, Paediatrics, Naples, Italy, 4 Second University of Naples, Paediatrics, Naples, Italy, 5 University of Messina, Paediatrics, Messina, Italy, 6 Univeristy of Torino, Paediatrics, Turin, Italy, 7 Bambin Gesù Hospital, Paediatrics, Rome, Italy, 8 Umberto I Hospital, Paediatrics, Rome, Italy, 9 University of Florence, Paediatrics, Florence, Italy

38 YEARS OF GROWTH HORMONE THERAPY - WHAT DOES THIS EXPERIENCE TEACH US? - A SINGLE CENTER CROSS-SECTIONAL RETROSPECTIVE STUDY-

Julia Rohayem¹, Hendrik Drechsel¹, BettinaTittel², Klaus Hinkel², Gabriele Hahn³, Ramona Ficker¹, Roland Pfaeffle⁴, Angela Huebner¹

1 Children´s Hospital, Department of Endocrinology Technical University Dresden, Dresden, Germany, 2 Center for Child Health Dresden-Friedrichstadt, Dresden, Germany, 3 Department of Radiology Technical University Dresden, Dresden, Germany, 4 Children´s Hospital, Department of Endocrinology, University of Leipzig, Leipzig, Germany

RETROSPECTIVE ANALYSIS OF IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP) IN GREEK CHILDREN. A 10-YEAR SINGLE INSTITUTION EXPERIENCE

Zoi Dorothea Pana, Basiliki Tsotoulidou, Athanasios Tragiannidis, Theodotis Papageorgiou, Eleni Balakou, Fani Athanassiadou

Pediatric Hematology Oncology Unit, AHEPA Hospital, Thessaloniki, Greece

HOSPITAL ACQUIRED ROTAVIRUS INFECTIONS: SUBSTANTIAL DISEASE BURDEN IN CANADIAN PEDIATRIC HOSPITALS

Nicole Le Saux¹, Julie Bettinger², Scott Halperin³, Wendy Vaudry⁴, David Scheifele²

1 Children’s hospital of Eastern Ontario, University of Ottawa, Ottawa, Canada, 2 Vaccine Evaluation Center, BC Children’s Hospital, Vancouver, Canada, 3 Canadian Center for Vaccinology, Dalhousie University, Halifax, Canada, 4 Stollery Children’s Hospital, Edmonton, Canada

THE SAFETY OF REPEATED ADMINISTRATION OF BOOSTRIX™, a REDUCED-ANTIGEN-CONTENT dTpa BOOSTER

Jussi Mertsola¹, Robert Booy², Fred Zepp³, Markus Knuf³, Quiushi He¹, Olivier Van Der Meeren⁴, Gunasekaran Ramakrishnan⁴, Froilan Celzo⁵, Jeanne-Marie Jacquet⁴, Nirjhar Chatterjee⁴

1 University of Turku and National Institute for Health and Welfare (THL), Turku, Finland, 2 Children's Hospital Westmead, Australia, 3 Department of Pediatrics and Adolescent Medicine, University Medical Center, Mainz, Germany, 4 GlaxoSmithKline Biologicals (GSK) Rixensart, Belgium, 5 University Hospital Antwerp (UZA), Antwerp, Belgium

CAUSES OF DEATH IN HIV-1 VERTICALLY INFECTED PAEDIATRIC PATIENTS IN MADRID (SPAIN) FROM 1982 TO 2008

Francisco J Climent¹, Claudia Palladino², Mª Isabel de José¹, Santiago Jimenez de Ory², Jose María Bellón³, Sara Guillén⁴, Mª Dolores Gurbindo⁵, Isabel Gonzalez-Tomé⁶, Mª José Mellado⁷, Jorge Martínez Pérez⁸, José Tomás Ramos⁴, Cristina Calvo⁹, Ma Ángeles Muñoz-Fernández²

1 Servicio Infecciosas Infantil, Hospital Universitario “La Paz”, Madrid, Spain, 2 Laboratorio de Inmuno-Biología Molecular, Hospital General Universitario “Gregorio Marañón”, Madrid,  Spain, 3 Unidad de Investigación, Fundación para la Investigación Biomédica del Hospital Gregorio Marañón, Madrid, Spain, 4 Servicio de Pediatría, Hospital Universitario de Getafe, Madrid, Spain, 5 Sección Inmuno-Pediatría, Hospital Materno Infantil “Gregorio Marañón”, Madrid, Spain, 6 Servicio de Infecciosas Pediátricas, Hospital Universitario “Doce de Octubre”, Madrid, Spain, 7 Servicio de Pediatría, Hospital Universitario “Carlos III”, Madrid, Spain, 8 Hospital Infantil Universitario “Niño Jesus”, Madrid, Spain, 9 Servicio de Pediatría, Hospital “Severo Ochoa”, Leganés, Madrid, Spain

COMMUNITY-ACQUIRED METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (CA-MRSA) DIFFUSION IN A POPULATION AT RISK OF HOSPITAL STRAIN ACQUISITION

Priscilla Cocchi, Giovanni Taccetti, Gemma Braccini, Francesca Trevisan, Cesare Braggion, Silvia Campana

Department  of Paediatrics, Cystic Fibrosis Centre, Meyer Hospital, Florence, Italy

THE OPTIMAL TREATMENT OF ASTHMA IN CHILDREN

Sur G.¹,Maria S²,Lucia  S.Salajan V³

1 University of Medicine and Pharmacy Cluj-Napoca, 2 Family Medicine, 3 Paediatrics Clinic II

Best Poster Awards (3)

PEDIATRIC CONGESTIVE HEART FAILURE – EVALUATION OF CARVEDILOL TREATMENT

Angela Butnariu, Mariana Andreica, Mariana Marc, Laurian Vlase, Sorin Leucuta

University of Medicine and Pharmacy Iuliu Hatieganu Cluj-Napoca, Cluj-Napoca, Romania

Important parameters IN THE DIAGNOSIS OF early PUBERAL maturation by general paediatrics: Our Experience On 162 Cases Of Precocious Puberty

Chiara Ciampi¹, Maurizio De Martino², Roberto Volpi³, Stefano Stagi⁴, Silvia Bonini¹, Salvatore Seminara¹, Fiorella Galluzzi¹, Roberto Salti¹, Tommaso Langiano⁵

1 Paediatric Department - Auxo-Endocrinologia, Azienda Ospedaliero-Universitaria A. Meyer, Firenze, 2 D.A.I.P.I. Director, Azienda Ospedaliero-Universitaria A. Meyer, Firenze, 3 Statistician, 4 U.O. Pediatria, Ospedale Villamarina, Piombino – Livorno, 5 General Menager, Azienda Ospedaliero-Universitaria A. Meyer, Firenze

PRIMARY CARE-BASED SURVEILLANCE TO ESTIMATE THE BURDEN OF ROTAVIRUS GASTROENTERITIS IN EUROPEAN CHILDREN AGED <5 YEARS

Carlo Giaquinto¹, Javier Diez-Domingo²,  Jose-Maria Baldo³,  Petr Pazdiora⁴, Johannes Forster⁵,  Marian Patrzalek⁶,  Ros Salter⁷,  Jean-Yves Pirçon⁸,  Montse Soriano-Gabarró⁸,  Nadia Meyer⁸

1 Department of Pediatrics, University of Padova, Padova, Italy, 2 Centro de Salud Nazaret, Valencia, Spain, 3 Centro de Salud Quart de Poblet, Valencia, Spain, 4 Medical Faculty of Charles University, Pilsen, Czech Republic, 5 St. Josefskrankenhaus, Freiburg, Germany, 6 Nzoz Promed, Pediatric Clinic, Kielce, Poland, 7 Primary Care Research and Clinical Trials Unit, Department of Primary Care and General Practice, University of Birmingham, Birmingham, United Kingdom, 8 GlaxoSmithKline Biologicals, Rixensart, Belgium

Young Investigators Awards (3)

IgA DEFICIENCY: A SILENT RISK FACTOR FOR ALLERGIC DISEASES IN CELIAC CHILDREN

Elisa Anastasio, Laura Giancotti, Mohamed Tassone, Monica Aloe, Nadia Severini, Serena Quattrone

Department of Pediatrics, University Magna Graecia of Catanzaro, Catanzaro, Italy

LONG-TERM (180 WEEKS) EFFICACY AND SAFETY OF FOSAMPRENAVIR IN HIV-INFECTED PAEDIATRIC PATIENTS IN CLINICAL PRACTICE

Verónica Briz¹, Claudia Palladino¹, Sergio Negre Policarpo², Laura Fernandez Silveira³, Mª Isabel de José⁴, Mª Isabel González-Tomé⁵, David Moreno6, Juan A. León Leal⁷, Mª Josefa Mellado⁸, Santiago J. de Ory¹, José T. Ramos⁹, Ma Ángeles Muñoz-Fernández¹

1 Laboratorio de Inmuno-Biología Molecular, Hospital General Universitario “Gregorio Marañón”, Madrid,  Spain, 2 Servicio de Enfermedades Infecciosas, Hospital Universitari “La Fe”, Valencia, Spain, 3 Servicio de Urgencias,  Hospital de Sagunto, Valencia, Spain, 4 Servicio Infecciosas Infantil, Hospital Universitario “La Paz”, Madrid, Spain, 5 Servicio de Infecciosas Pediátricas, Hospital Universitario “Doce de Octubre”, Madrid, Spain, 6 Unidad de Infectología e Inmunodeciciencias. Servicio de Pediatría, Hospital Regional Universitario “Carlos Haya”, Málaga, Spain, 7 Unidad de Infectología/Medicina Interna Pediátrica, Hospital Infantil Unversitario “Virgen del Rocío”, Sevilla, Spain, 8 Servicio de Pediatría. Hospital Universitario “Carlos III”, Madrid, Spain, 9 Servicio de Pediatría. Hospital Universitario de Getafe, Madrid, Spain

OUTCOME OF HIV-POSITIVE PREGNANT WOMEN SEEN IN A PROVINCIAL UNIT IN EAST ANGLIA

Abimbola M Akinde¹, Tubonye C Harry², Jane Preston³, Richard Stocks⁴

1 School of Medicine, Health Policy & Practice, University of East Anglia, Norwich, United Kingdom, 2 Department of Genitourinary Medicine, James Paget University Hospital, Great Yarmouth, United Kingdom, 3 Department of Obstetrics & Gynaecology, James Paget University Hospital, Great Yarmouth, United Kingdom, 4 Department of Paediatrics, James Paget University Hospital, Great Yarmouth, United Kingdom